173 related articles for article (PubMed ID: 2201435)
1. Alpha-interferon structure and natural killer cell stimulatory activity.
Li BL; Zhao XX; Liu XY; Kim HS; Raska K; Ortaldo JR; Schwartz B; Pestka S
Cancer Res; 1990 Sep; 50(17):5328-32. PubMed ID: 2201435
[TBL] [Abstract][Full Text] [Related]
2. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
[TBL] [Abstract][Full Text] [Related]
3. Cloning, expression and biological activity of a new variant of human interferon alpha identified in virus induced lymphoblastoid cells.
Cohen S; Velan B; Grosfeld H; Shalita Z; Leitner M; Shafferman A
Dev Biol Stand; 1985; 60():111-22. PubMed ID: 2995168
[TBL] [Abstract][Full Text] [Related]
4. Comparison of augmentation of human natural killer cell cytotoxicity by interferon-alpha subtypes.
Verhagen A; Mackay IR; Rowley M; Tymms M
Nat Immun Cell Growth Regul; 1990; 9(5):325-33. PubMed ID: 2077397
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
Edwards BS; Hawkins MJ; Borden EC
Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
[TBL] [Abstract][Full Text] [Related]
6. Single amino acid substitutions at conserved residues of human interferon-alpha can effect antiviral specific activity.
Nisbet IT; Beilharz MW; Hertzog PJ; Tymms MJ; Linnane AW
Biochem Int; 1985 Sep; 11(3):301-9. PubMed ID: 3904757
[TBL] [Abstract][Full Text] [Related]
7. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
Brunda MJ; Rosenbaum D
Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
[TBL] [Abstract][Full Text] [Related]
8. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
9. [Cloning, expression and purification of interferon-kappa, a novel human interferon, and its antiviral activity].
Zhang H; Duan ZJ; Zhu JG; Peng FW; Li WP; Gao HC; Xie ZP; Wang YE; Hou YD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):223-6. PubMed ID: 16261202
[TBL] [Abstract][Full Text] [Related]
10. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
Okabe M; Gomi K; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of recombinant human leukocyte interferons on cell surface antigen expression.
Greiner JW; Fisher PB; Pestka S; Schlom J
Cancer Res; 1986 Oct; 46(10):4984-90. PubMed ID: 2944575
[TBL] [Abstract][Full Text] [Related]
12. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide sequence and expression in E. coli of a human interferon-alpha gene selected from a genomic library using synthetic oligonucleotides.
Linnane AW; Beilharz MW; McMullen GL; Macreadie IG; Murphy M; Nisbet IT; Novitski CE; Woodrow GC
Biochem Int; 1984 May; 8(5):725-32. PubMed ID: 6089830
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of human natural killer cell activity by influenza virus antigens produced in Escherichia coli.
Rees RC; Dalton BJ; Young JF; Hanna N; Poste G
J Biol Response Mod; 1987 Feb; 6(1):69-87. PubMed ID: 3549981
[TBL] [Abstract][Full Text] [Related]
15. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
[TBL] [Abstract][Full Text] [Related]
16. [Human natural killer activity in selected test systems and tissue compartments: natural killer cell modulation by biological response modifiers].
Klappacher G
Wien Klin Wochenschr; 1988 Nov; 100(22):743-6. PubMed ID: 3149079
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell activity in patients with multiple sclerosis given alpha interferon.
Rice GP; Casali P; Merigan TC; Oldstone MB
Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954
[TBL] [Abstract][Full Text] [Related]
18. Cloning of a bovine interferon-alpha gene subfamily and comparisons between genetically engineered and leukocyte bovine interferons.
Velan B; Cohen S; Grosfeld H; Shalita Z; Shafferman A
Dev Biol Stand; 1985; 60():355-69. PubMed ID: 3899795
[TBL] [Abstract][Full Text] [Related]
19. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity.
Yamamoto S; Yamamoto T; Kataoka T; Kuramoto E; Yano O; Tokunaga T
J Immunol; 1992 Jun; 148(12):4072-6. PubMed ID: 1376349
[TBL] [Abstract][Full Text] [Related]
20. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen.
Brooks CG; Holscher M; Urdal D
J Immunol; 1985 Aug; 135(2):1145-52. PubMed ID: 2409140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
